title: Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
authors.forename: Markus
authors.initials: M
authors.lastname: Magerl
authors.forename: Petra
authors.initials: P
authors.lastname: Staubach
authors.forename: Sabine
authors.initials: S
authors.lastname: Altrichter
authors.forename: Elena
authors.initials: E
authors.lastname: Ardelean
authors.forename: Karoline
authors.initials: K
authors.lastname: Krause
authors.forename: Martin
authors.initials: M
authors.lastname: Metz
authors.forename: Karsten
authors.initials: K
authors.lastname: Weller
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab